To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Cinven makes second pharma play with new fund
The London-headquartered firm has funded the acquisition of Amdipharm with capital from its fifth fund, which has now reached €4bn as it pursues a €5bn target.
